The inflammatory role of platelets via their TLRs and Siglec receptors

Frontiers in Immunology

Volumn 6, Issue MAR, 2015, Pages

  Cognasse, Fabrice ^a,b   Nguyen, Kim Anh ^b   Damien, Pauline ^b   McNicol, Archibald ^c   Pozzetto, Bruno ^b   Hamzeh Cognasse, Hind ^b   Garraud, Olivier ^b,d  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITY OF MANITOBA   (Canada)

^d INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

Cytokine chemokine; Inflammation; Innate immunity; Platelets; Siglec; TLR

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CD14 ANTIGEN; DIACYLGLYCEROL; G PROTEIN COUPLED RECEPTOR; HLA ANTIGEN CLASS 1; INOSITOL PHOSPHATE; INOSITOL TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C; PROTEIN KINASE C; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; THROMBIN; THROMBOCYTE ANTIGEN; THROMBOXANE A2; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNINDEXED DRUG;

APOPTOSIS; AUTOIMMUNE DISEASE; HEMOSTASIS; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MEGAKARYOCYTE; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS; THROMBOCYTE; THROMBOCYTOPENIA; THROMBOSIS;

EID: 84926672796     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00083     Document Type: Review

References (157)

1. Blajchman MA. Platelet transfusions: an historical perspective. Hematology Am Soc Hematol Educ Program (2008) 2008:197. doi: 10.1182/asheducation-2008.1.197
2. Alio JL, Arnalich-Montiel F, Rodriguez AE. The role of "eye platelet rich plasma" (E-PRP) for wound healing in ophthalmology. Curr Pharm Biotechnol (2012) 13:1257-65. doi:10.2174/138920112800624355
3. McCullough J. Overview of platelet transfusion. Semin Hematol (2010) 47:235-42. doi:10.1053/j.seminhematol.2010.04.001
4. MacLennan S, Williamson LM. Risks of fresh frozen plasma and platelets. J Trauma (2006) 60:S46-50. doi:10.1097/01.ta.0000199546.22925.31
5. Sachs UJ. Fetal/neonatal alloimmune thrombocytopenia. Thromb Res (2013) 131(Suppl 1):S42-6. doi:10.1016/S0049-3848(13)70020-3
6. Zimmermann R, Wittmann G, Zingsem J, Blasczyk R, Weisbach V, Eckstein R. Antibodies to private and public HLA class I epitopes in platelet recipients. Transfusion (1999) 39:772-80. doi:10.1046/j.1537-2995.1999.39070772.x
7. Golebiewska EM, Poole AW. Platelet secretion: from haemostasis to wound healing and beyond. Blood Rev (2014). doi:10.1016/j.blre.2014.10.003
8. Jenne CN, Urrutia R, Kubes P. Platelets: bridging hemostasis, inflammation, and immunity. Int J Lab Hematol (2013) 35:254-61. doi:10.1111/ijlh.12084
9. Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, et al. Platelet functions beyond haemostasis. J Thromb Haemost (2009) 7:1759-66. doi:10.1111/j.1538-7836.2009.03586.x
10. Garraud O, Hamzeh-Cognasse H, Pozzetto B, Cavaillon JM, Cognasse F. Bench-to-bedside review: platelets and active immune functions-new clues for immunopathology? Crit Care (2013) 17:236. doi:10.1186/cc12716
11. Gachet C. Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol (2006) 46:277-300. doi:10.1146/annurev.pharmtox.46.120604.141207
12. Dorsam RT, Kunapuli SP. Central role of the P2Y12 receptor in platelet activation. J Clin Invest (2004) 113:340-5. doi:10.1172/JCI20986
13. Hechler B, Lenain N, Marchese P, Vial C, Heim V, Freund M, et al. A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo. J Exp Med (2003) 198:661-7. doi:10.1084/jem.20030144
14. Erhardt JA, Toomey JR, Douglas SA, Johns DG. P2X1 stimulation promotes thrombin receptor-mediated platelet aggregation. J Thromb Haemost (2006) 4:882-90. doi:10.1111/j.1538-7836.2006.01849.x
15. Fabre JE, Nguyen M, Latour A, Keifer JA, Audoly LP, Coffman TM, et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med (1999) 5:1199-202. doi:10.1038/13522
16. Van Holten TC, Bleijerveld OB, Wijten P, De Groot PG, Heck AJ, Barendrecht AD, et al. Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets. Cardiovasc Res (2014) 103:140-6. doi:10.1093/cvr/cvu113
17. Clemetson KJ. Platelets and primary haemostasis. Thromb Res (2012) 129:220-4. doi:10.1016/j.thromres.2011.11.036
18. Ramachandran R, Hollenberg MD. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol (2008) 153(Suppl 1):S263-82. doi:10.1038/sj.bjp.0707507
19. Cognasse F, Semple JW, Garraud O. Platelets as potential immunomodulators: is there a role for platelet toll-like receptors? Curr Immunol Rev (2007) 3:109-15. doi:10.2174/157339507780655522
20. Von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res (2007) 100:27-40. doi:10.1161/01.RES.0000252802.25497.b7
21. Cox D. Bacteria-platelet interactions. J Thromb Haemost (2009) 7:1865-6. doi:10.1111/j.1538-7836.2009.03611.x
22. Flaujac C, Boukour S, Cramer-Borde E. Platelets and viruses: an ambivalent relationship. Cell Mol Life Sci (2010) 67:545-56. doi:10.1007/s00018-009-0209-x
23. Garraud O, Cognasse F. Platelet toll-like receptor expression: the link between "danger" ligands and inflammation. Inflamm Allergy Drug Targets (2010) 9:322-33. doi:10.2174/187152810793937991
24. Cox D, Kerrigan SW, Watson SP. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost (2011) 9:1097-107. doi:10.1111/j.1538-7836.2011.04264.x
25. Arman M, Krauel K, Tilley DO, Weber C, Cox D, Greinacher A, et al. Amplification of bacteria-induced platelet activation is triggered by FcgammaRIIA, integrin alphaIIbbeta3, and platelet factor 4. Blood (2014) 123:3166-74. doi:10.1182/blood-2013-11-540526
26. Speth C, Rambach G, Lass-Florl C. Platelet immunology in fungal infections. Thromb Haemost (2014) 112:632-9. doi:10.1160/TH14-01-0074
27. Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res (2002) 22:913-22. doi:10.1089/10799900260286623
28. Vincent JL, Yagushi A, Pradier O. Platelet function in sepsis. Crit Care Med (2002) 30:S313-7. doi:10.1097/00003246-200205001-00022
29. Yaguchi A, Lobo FL, Vincent JL, Pradier O. Platelet function in sepsis. J Thromb Haemost (2004) 2:2096-102. doi:10.1111/j.1538-7836.2004.01009.x
30. Yeaman MR. Bacterial-platelet interactions: virulence meets host defense. Future Microbiol (2010) 5:471-506. doi:10.2217/fmb.09.112
31. Yeaman MR. Platelets in defense against bacterial pathogens. Cell Mol Life Sci (2010) 67:525-44. doi:10.1007/s00018-009-0210-4
32. Wong CH, Jenne CN, Petri B, Chrobok NL, Kubes P. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol (2013) 14:785-92. doi:10.1038/ni.2631
33. Yeaman MR. Platelets: at the nexus of antimicrobial defence. Nat Rev Microbiol (2014) 12:426-37. doi:10.1038/nrmicro3269
34. Shiraki R, Inoue N, Kawasaki S, Takei A, Kadotani M, Ohnishi Y, et al. Expression of toll-like receptors on human platelets. Thromb Res (2004) 113:379-85. doi:10.1016/j.thromres.2004.03.023
35. Semple JW, Italiano JE Jr, Freedman J. Platelets and the immune continuum. Nat Rev Immunol (2011) 11:264-74. doi:10.1038/nri2956
36. Li C, Li J, Li Y, Lang S, Yougbare I, Zhu G, et al. Crosstalk between platelets and the immune System: old systems with new discoveries. Adv Hematol (2012) 2012:384685. doi:10.1155/2012/384685
37. Anabel AS, Eduardo PC, Antonio HC, Carlos SM, Juana NM, Honorio TA, et al. Human platelets express toll-like receptor 3 and respond to poly I:C. Hum Immunol (2014) 75(12):1244-51. doi:10.1016/j.humimm.2014.09.013
38. Koupenova M, Vitseva O, Mackay CR, Beaulieu LM, Benjamin EJ, Mick E, et al. Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. Blood (2014) 124:791-802. doi:10.1182/blood-2013-11-536003
39. Elzey BD, Tian J, Jensen RJ, Swanson AK, Lees JR, Lentz SR, et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity (2003) 19:9-19. doi:10.1016/S1074-7613(03)00177-8
40. Garraud O, Berthet J, Hamzeh-Cognasse H, Cognasse F. Pathogen sensing, subsequent signalling, and signalosome in human platelets. Thromb Res (2011) 127:283-6. doi:10.1016/j.thromres.2010.10.015
41. Mantovani A, Garlanda C. Platelet-macrophage partnership in innate immunity and inflammation. Nat Immunol (2013) 14:768-70. doi:10.1038/ni.2666
42. Montrucchio G, Bosco O, Del Sorbo L, Fascio Pecetto P, Lupia E, Goffi A, et al. Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. Thromb Haemost (2003) 90:872-81. doi:10.1267/THRO03050872
43. Ward JR, Bingle L, Judge HM, Brown SB, Storey RF, Whyte MK, et al. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost (2005) 94:831-8. doi:10.1160/TH05-01-0009
44. Jayachandran M, Brunn GJ, Karnicki K, Miller RS, Owen WG, Miller VM. In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. J Appl Physiol (2007) 102:429-33. doi:10.1152/japplphysiol.01576.2005
45. Phipps RP, Kaufman J, Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet (2001) 357:2023-4. doi:10.1016/S0140-6736(00)05108-4
46. Freedman JE. CD40-CD40L and platelet function: beyond hemostasis. Circ Res (2003) 92:944-6. doi:10.1161/01.RES.0000074030.98009.FF
47. Davi G, Ferroni P. CD40-CD40L interactions in platelet activation. Thromb Haemost (2005) 93:1011-2. doi:10.1160/TH05-04-0270
48. Elzey BD, Ratliff TL, Sowa JM, Crist SA. Platelet CD40L at the interface of adaptive immunity. Thromb Res (2011) 127:180-3. doi:10.1016/j.thromres.2010.10.011
49. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature (1998) 391:591-4. doi:10.1038/35393
50. Danese S, Fiocchi C. Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease. Crit Rev Immunol (2005) 25:103-21. doi:10.1615/CritRevImmunol.v25.i2.20
51. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest (2005) 115:3378-84. doi:10.1172/JCI27196
52. Bozza FA, Shah AM, Weyrich AS, Zimmerman GA. Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol (2009) 40:123-34. doi:10.1165/rcmb.2008-0241TR
53. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science (2010) 327:580-3. doi:10.1126/science.1181928
54. Phipps RP. Platelets at the interface between thrombosis, inflammation and immunity. Thromb Res (2011) 127:179. doi:10.1016/j.thromres.2010.10.014
55. Rutella S, Vetrano S, Correale C, Graziani C, Sturm A, Spinelli A, et al. Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature. J Cell Mol Med (2011) 15:625-34. doi:10.1111/j.1582-4934.2010.01033.x
56. Smith TL, Weyrich AS. Platelets as central mediators of systemic inflammatory responses. Thromb Res (2011) 127:391-4. doi:10.1016/j.thromres.2010.10.013
57. Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res (2013) 112:1506-19. doi:10.1161/CIRCRESAHA.113.300512
58. Boudreau LH, Duchez AC, Cloutier N, Soulet D, Martin N, Bollinger J, et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood (2014) 124:2173-83. doi:10.1182/blood-2014-05-573543
59. Sansonetti PJ, Medzhitov R. Learning tolerance while fighting ignorance. Cell (2009) 138:416-20. doi:10.1016/j.cell.2009.07.024
60. Sansonetti PJ. To be or not to be a pathogen: that is the mucosally relevant question. Mucosal Immunol (2011) 4:8-14. doi:10.1038/mi.2010.77
61. Damas JK, Jensenius M, Ueland T, Otterdal K, Yndestad A, Froland SS, et al. Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets. J Immunol (2006) 177:2699-706. doi:10.4049/jimmunol.177.4.2699
62. Beaulieu LM, Freedman JE. The role of inflammation in regulating platelet production and function: toll-like receptors in platelets and megakaryocytes. Thromb Res (2010) 125:205-9. doi:10.1016/j.thromres.2009.11.004
63. Ogura H, Kawasaki T, Tanaka H, Koh T, Tanaka R, Ozeki Y, et al. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J Trauma (2001) 50:801-9. doi:10.1097/00005373-200105000-00005
64. Pitchford SC, Yano H, Lever R, Riffo-Vasquez Y, Ciferri S, Rose MJ, et al. Platelets are essential for leukocyte recruitment in allergic inflammation. J Allergy Clin Immunol (2003) 112:109-18. doi:10.1067/mai.2003.1514
65. Zeller JA, Lenz A, Eschenfelder CC, Zunker P, Deuschl G. Platelet-leukocyte interaction and platelet activation in acute stroke with and without preceding infection. Arterioscler Thromb Vasc Biol (2005) 25:1519-23. doi:10.1161/01.ATV.0000167524.69092.16
66. Li N. Platelet-lymphocyte cross-talk. J Leukoc Biol (2008) 83:1069-78. doi:10.1189/jlb.0907615
67. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev (2007) 21:99-111. doi:10.1016/j.blre.2006.06.001
68. Ma AC, Kubes P. Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. J Thromb Haemost (2008) 6:415-20. doi:10.1111/j.1538-7836.2007.02865.x
69. Asaduzzaman M, Lavasani S, Rahman M, Zhang S, Braun OO, Jeppsson B, et al. Platelets support pulmonary recruitment of neutrophils in abdominal sepsis. Crit Care Med (2009) 37:1389-96. doi:10.1097/CCM.0b013e31819ceb71
70. Kornerup KN, Salmon GP, Pitchford SC, Liu WL, Page CP. Circulating platelet-neutrophil complexes are important for subsequent neutrophil activation and migration. J Appl Physiol (2010) 109:758-67. doi:10.1152/japplphysiol.01086.2009
71. Johansson D, Shannon O, Rasmussen M. Platelet and neutrophil responses to Gram positive pathogens in patients with bacteremic infection. PLoS One (2011) 6:e26928. doi:10.1371/journal.pone.0026928
72. Caudrillier A, Kessenbrock K, Gilliss BM, Nguyen JX, Marques MB, Monestier M, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest (2012) 122:2661-71. doi:10.1172/JCI61303
73. Duerschmied D, Suidan GL, Demers M, Herr N, Carbo C, Brill A, et al. Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. Blood (2013) 121:1008-15. doi:10.1182/blood-2012-06-437392
74. Haselmayer P, Grosse-Hovest L, Von Landenberg P, Schild H, Radsak MP. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood (2007) 110:1029-35. doi:10.1182/blood-2007-01-069195
75. Nash GB. Adhesion between platelets and leukocytes or endothelial cells. Methods Mol Biol (2004) 272:199-213. doi:10.1385/1-59259-782-3:199
76. McGregor L, Martin J, McGregor JL. Platelet-leukocyte aggregates and derived microparticles in inflammation, vascular remodelling and thrombosis. Front Biosci (2006) 11:830-7. doi:10.2741/1840
77. Flaumenhaft R, Mairuhu AT, Italiano JE. Platelet-and megakaryocyte-derived microparticles. Semin Thromb Hemost (2010) 36:881-7. doi:10.1055/s-0030-1267042
78. Italiano JE Jr, Mairuhu AT, Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol (2010) 17:578-84. doi:10.1097/MOH.0b013e32833e77ee
79. Vasina E, Heemskerk JW, Weber C, Koenen RR. Platelets and platelet-derived microparticles in vascular inflammatory disease. Inflamm Allergy Drug Targets (2010) 9:346-54. doi:10.2174/187152810793938008
80. Land WG. Transfusion-related acute lung injury: the work of DAMPs. Transfus Med Hemother (2013) 40:3-13. doi:10.1159/000345688
81. Lee YL, King MB, Gonzalez RP, Brevard SB, Frotan MA, Gillespie MN, et al. Blood transfusion products contain mitochondrial DNA damage-associated molecular patterns: a potential effector of transfusion-related acute lung injury. J Surg Res (2014) 191:286-9. doi:10.1016/j.jss.2014.06.003
82. Varki A. Since there are PAMPs and DAMPs, there must be SAMPs? Glycan "self-associated molecular patterns" dampen innate immunity, but pathogens can mimic them. Glycobiology (2011) 21:1121-4. doi:10.1093/glycob/cwr087
83. Freeman SD, Kelm S, Barber EK, Crocker PR. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood (1995) 85:2005-12.
84. Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol (2007) 7:255-66. doi:10.1038/nri2056
85. McMillan SJ, Crocker PR. CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease. Carbohydr Res (2008) 343:2050-6. doi:10.1016/j.carres.2008.01.009
86. Cao H, Crocker PR. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation? Immunology (2011) 132:18-26. doi:10.1111/j.1365-2567.2010.03368.x
87. Crocker PR, McMillan SJ, Richards HE. CD33-related siglecs as potential modulators of inflammatory responses. Ann N Y Acad Sci (2012) 1253:102-11. doi:10.1111/j.1749-6632.2011.06449.x
88. Nguyen KA, Hamzeh-Cognasse H, Palle S, Anselme-Bertrand I, Arthaud CA, Chavarin P, et al. Role of siglec-7 in apoptosis in human platelets. PLoS One (2014) 9:e106239. doi:10.1371/journal.pone.0106239
89. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol (2010) 11:373-84. doi:10.1038/ni.1863
90. Werling D, Jungi TW. Toll-like receptors linking innate and adaptive immune response. Vet Immunol Immunopathol (2003) 91:1-12. doi:10.1016/S0165-2427(02)00228-3
91. Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol (2005) 174:4453-60. doi:10.4049/jimmunol.174.8.4453
92. Kawai T, Akira S. TLR signaling. Semin Immunol (2007) 19:24-32. doi:10.1016/j.smim.2006.12.004
93. Beutler BA. TLRs and innate immunity. Blood (2009) 113:1399-407. doi:10.1182/blood-2008-07-019307
94. O'reilly MK, Paulson JC. Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol Sci (2009) 30:240-8. doi:10.1016/j.tips.2009.02.005
95. Paulson JC, Macauley MS, Kawasaki N. Siglecs as sensors of self in innate and adaptive immune responses. Ann N Y Acad Sci (2012) 1253:37-48. doi:10.1111/j.1749-6632.2011.06362.x
96. Pillai S, Netravali IA, Cariappa A, Mattoo H. Siglecs and immune regulation. Annu Rev Immunol (2012) 30:357-92. doi:10.1146/annurev-immunol-020711-075018
97. Varki A, Gagneux P. Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci (2012) 1253:16-36. doi:10.1111/j.1749-6632.2012.06517.x
98. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell (2006) 124:783-801. doi:10.1016/j.cell.2006.02.015
99. Lauw FN, Caffrey DR, Golenbock DT. Of mice and man: TLR11 (finally) finds profilin. Trends Immunol (2005) 26:509-11. doi:10.1016/j.it.2005.08.006
100. Yu LX, Yan L, Yang W, Wu FQ, Ling Y, Chen SZ, et al. Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein. Nat Commun (2014) 5:5256. doi:10.1038/ncomms6256
101. Maugeri N, Campana L, Gavina M, Covino C, De Metrio M, Panciroli C, et al. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost (2014) 12:2074-88. doi:10.1111/jth.12710
102. Maugeri N, Rovere-Querini P, Baldini M, Baldissera E, Sabbadini MG, Bianchi ME, et al. Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis. Antioxid Redox Signal (2014) 20:1060-74. doi:10.1089/ars.2013.5298
103. Vogel S, Chatterjee M, Metzger K, Borst O, Geisler T, Seizer P, et al. Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET. J Biol Chem (2014) 289:11068-82. doi:10.1074/jbc.M113.530287
104. Szatmary Z. Molecular biology of toll-like receptors. Gen Physiol Biophys (2012) 31:357-66. doi:10.4149/gpb_2012_048
105. Thon JN, Peters CG, Machlus KR, Aslam R, Rowley J, Macleod H, et al. T granules in human platelets function in TLR9 organization and signaling. J Cell Biol (2012) 198:561-74. doi:10.1083/jcb.201111136
106. Andonegui G, Kerfoot SM, McNagny K, Ebbert KV, Patel KD, Kubes P. Platelets express functional toll-like receptor-4. Blood (2005) 106:2417-23. doi:10.1182/blood-2005-03-0916
107. Boiko JR, Borghesi L. Hematopoiesis sculpted by pathogens: toll-like receptors and inflammatory mediators directly activate stem cells. Cytokine (2012) 57:1-8. doi:10.1016/j.cyto.2011.10.005
108. Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, Garraud O. Evidence of toll-like receptor molecules on human platelets. Immunol Cell Biol (2005) 83:196-8. doi:10.1111/j.1440-1711.2005.01314.x
109. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, et al. Platelet toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood (2006) 107:637-41. doi:10.1182/blood-2005-06-2202
110. St Paul M, Paolucci S, Barjesteh N, Wood RD, Schat KA, Sharif S. Characterization of chicken thrombocyte responses to toll-like receptor ligands. PLoS One (2012) 7:e43381. doi:10.1371/journal.pone.0043381
111. Berthet J, Damien P, Hamzeh-Cognasse H, Pozzetto B, Garraud O, Cognasse F. toll-like receptor 4 signal transduction in platelets: novel pathways. Br J Haematol (2010) 151:89-92. doi:10.1111/j.1365-2141.2010.08292.x
112. Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature (2009) 458:1191-5. doi:10.1038/nature07830
113. Rondina MT, Schwertz H, Harris ES, Kraemer BF, Campbell RA, Mackman N, et al. The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost (2011) 9:748-58. doi:10.1111/j.1538-7836.2011.04208.x
114. Semple JW, Aslam R, Kim M, Speck ER, Freedman J. Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets. Blood (2007) 109:4803-5. doi:10.1182/blood-2006-12-062695
115. Tremblay T, Aubin E, Lemieux R, Bazin R. Picogram doses of lipopolysaccharide exacerbate antibody-mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice. Br J Haematol (2007) 139:297-302. doi:10.1111/j.1365-2141.2007.06777.x
116. Li Z, Zhang G, Marjanovic JA, Ruan C, Du X. A platelet secretion pathway mediated by cGMP-dependent protein kinase. J Biol Chem (2004) 279:42469-75. doi:10.1074/jbc.M401532200
117. Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB, et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol (2009) 182:7997-8004. doi:10.4049/jimmunol.0802884
118. Berthet J, Damien P, Hamzeh-Cognasse H, Arthaud CA, Eyraud MA, Zeni F, et al. Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion. Clin Immunol (2012) 145:189-200. doi:10.1016/j.clim.2012.09.004
119. Brown GT, McIntyre TM. Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1beta-rich microparticles. J Immunol (2011) 186:5489-96. doi:10.4049/jimmunol.1001623
120. Stahl AL, Svensson M, Morgelin M, Svanborg C, Tarr PI, Mooney JC, et al. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets via TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood (2006) 108:167-76. doi:10.1182/blood-2005-08-3219
121. Shashkin PN, Brown GT, Ghosh A, Marathe GK, McIntyre TM. Lipopolysaccharide is a direct agonist for platelet RNA splicing. J Immunol (2008) 181:3495-502. doi:10.4049/jimmunol.181.5.3495
122. Cognasse F, Osselaer JC, Payrat JM, Chavarin P, Corash L, Garraud O. Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment. Transfusion (2008) 48:809-13. doi:10.1111/j.1537-2995.2008.01655.x
123. Kappelmayer J, Beke Debreceni I, Vida A, Antal-Szalmas P, Clemetson KJ, Nagy B Jr. Distinct effects of Re-and S-forms of LPS on modulating platelet activation. J Thromb Haemost (2013) 11(4):775-8. doi:10.1111/jth.12151
124. Kalvegren H, Skoglund C, Helldahl C, Lerm M, Grenegard M, Bengtsson T. toll-like receptor 2 stimulation of platelets is mediated by purinergic P2X1-dependent Ca2+ mobilisation, cyclooxygenase and purinergic P2Y1 and P2Y12 receptor activation. Thromb Haemost (2010) 103:398-407. doi:10.1160/TH09-07-0442
125. Morello F, Perino A, Hirsch E. Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc Res (2009) 82:261-71. doi:10.1093/cvr/cvn325
126. Ha T, Hu Y, Liu L, Lu C, McMullen JR, Kelley J, et al. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Cardiovasc Res (2010) 87:694-703. doi:10.1093/cvr/cvq116
127. Blair P, Rex S, Vitseva O, Beaulieu L, Tanriverdi K, Chakrabarti S, et al. Stimulation of toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res (2008) 104:346-54. doi:10.1161/CIRCRESAHA.108.185785
128. Assinger A, Laky M, Badrnya S, Esfandeyari A, Volf I. Periodontopathogens induce expression of CD40L on human platelets via TLR2 and TLR4. Thromb Res (2012) 130:e73-8. doi:10.1016/j.thromres.2012.04.017
129. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, et al. CD36 is a sensor of diacylglycerides. Nature (2005) 433:523-7. doi:10.1038/nature03253
130. Rex S, Beaulieu LM, Perlman DH, Vitseva O, Blair PS, McComb ME, et al. Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release. Thromb Haemost (2009) 102:97-110. doi:10.1160/TH08-08-0513
131. Assinger A, Laky M, Schabbauer G, Hirschl AM, Buchberger E, Binder BR, et al. Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2. J Thromb Haemost (2011) 9:799-809. doi:10.1111/j.1538-7836.2011.04193.x
132. Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL, et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood (2011) 118:1952-61. doi:10.1182/blood-2011-03-343061
133. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A toll-like receptor recognizes bacterial DNA. Nature (2000) 408:740-5. doi:10.1038/35047123
134. Thon JN, Italiano JE. Platelets: production, morphology and ultrastructure. Handb Exp Pharmacol (2012) 210:3-22. doi:10.1007/978-3-642-29423-5_1
135. Panigrahi S, Ma Y, Hong L, Gao D, West XZ, Salomon RG, et al. Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyper-reactivity and thrombosis. Circ Res (2013) 112(1):103-12. doi:10.1161/CIRCRESAHA.112.274241
136. Varki A, Angata T. Siglecs-the major subfamily of I-type lectins. Glycobiology (2006) 16:1R-27R. doi:10.1093/glycob/cwj008
137. Kelm S, Pelz A, Schauer R, Filbin MT, Tang S, De Bellard ME, et al. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol (1994) 4:965-72. doi:10.1016/S0960-9822(00)00220-7
138. Zhang J, Raper A, Sugita N, Hingorani R, Salio M, Palmowski MJ, et al. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood (2006) 107:3600-8. doi:10.1182/blood-2005-09-3842
139. Angata T, Hayakawa T, Yamanaka M, Varki A, Nakamura M. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates. FASEB J (2006) 20:1964-73. doi:10.1096/fj.06-5800com
140. Angata T, Tabuchi Y, Nakamura K, Nakamura M. Siglec-15: an immune system Siglec conserved throughout vertebrate evolution. Glycobiology (2007) 17:838-46. doi:10.1093/glycob/cwm049
141. Cao H, Lakner U, De Bono B, Traherne JA, Trowsdale J, Barrow AD. SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans. Eur J Immunol (2008) 38:2303-15. doi:10.1002/eji.200738078
142. Liu Y, Chen GY, Zheng P. Sialoside-based pattern recognitions discriminating infections from tissue injuries. Curr Opin Immunol (2011) 23:41-5. doi:10.1016/j.coi.2010.10.004
143. Rapoport E, Mikhalyov I, Zhang J, Crocker P, Bovin N. Ganglioside binding pattern of CD33-related siglecs. Bioorg Med Chem Lett (2003) 13:675-8. doi:10.1016/S0960-894X(02)00998-8
144. Ito A, Handa K, Withers DA, Satoh M, Hakomori S. Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression. FEBS Lett (2001) 498:116-20. doi:10.1016/S0014-5793(01)02476-0
145. Nicoll G, Avril T, Lock K, Furukawa K, Bovin N, Crocker PR. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and-independent mechanisms. Eur J Immunol (2003) 33:1642-8. doi:10.1002/eji.200323693
146. Attrill H, Imamura A, Sharma RS, Kiso M, Crocker PR, Van Aalten DM. Siglec-7 undergoes a major conformational change when complexed with the alpha(2,8)-disialylganglioside GT1b. J Biol Chem (2006) 281:32774-83. doi:10.1074/jbc.M601714200
147. Kivi E, Elima K, Aalto K, Nymalm Y, Auvinen K, Koivunen E, et al. Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate. Blood (2009) 114:5385-92. doi:10.1182/blood-2009-04-219253
148. Martini F, Riondino S, Pignatelli P, Gazzaniga PP, Ferroni P, Lenti L. Involvement of GD3 in platelet activation. A novel association with Fcgamma receptor. Biochim Biophys Acta (2002) 1583:297-304. doi:10.1016/S1388-1981(02)00250-0
149. Li J, Xia Y, Bertino AM, Coburn JP, Kuter DJ. The mechanism of apoptosis in human platelets during storage. Transfusion (2000) 40:1320-9. doi:10.1046/j.1537-2995.2000.40111320.x
150. Leytin V, Allen DJ, Mutlu A, Mykhaylov S, Lyubimov E, Freedman J. Platelet activation and apoptosis are different phenomena: evidence from the sequential dynamics and the magnitude of responses during platelet storage. Br J Haematol (2008) 142:494-7. doi:10.1111/j.1365-2141.2008.07209.x
151. Leytin V. Apoptosis in the anucleate platelet. Blood Rev (2012) 26:51-63. doi:10.1016/j.blre.2011.10.002
152. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost (2009) 101:439-51. doi:10.1160/TH08-08-0521
153. Clemetson KJ. Platelets and pathogens. Cell Mol Life Sci (2010) 67:495-8. doi:10.1007/s00018-009-0204-2
154. Gill R, Tsung A, Billiar T. Linking oxidative stress to inflammation: toll-like receptors. Free Radic Biol Med (2010) 48:1121-32. doi:10.1016/j.freeradbiomed.2010.01.006
155. Ando M, Shoji T, Tu W, Higuchi H, Nishijima KI, Iijima S. Lectin-dependent localization of cell surface sialic acid-binding lectin Siglec-9. Cytotechnology (2014). doi:10.1007/s10616-014-9691-6
156. Ishida A, Akita K, Mori Y, Tanida S, Toda M, Inoue M, et al. Negative regulation of toll-like receptor-4 signaling through the binding of glycosylphosphatidylinositol-anchored glycoprotein, CD14, with the sialic acid-binding lectin, CD33. J Biol Chem (2014) 289:25341-50. doi:10.1074/jbc.M113.523480
157. Paulson JC, Kawasaki N. Sialidase inhibitors DAMPen sepsis. Nat Biotechnol (2011) 29:406-7. doi:10.1038/nbt.1859